Shilpa Medicare Limited is all set to acquire FTF Pharma Private Limited through share purchase agreement (SPA). As per the terms of draft share purchase agreement, the acquisition would be completed on or before April 30, 2023. The objective of Shilpa Medicare behind this acquisition is to enhance its research and development (R&D) facilities as well as to enhance its product extension. Shilpa Medicare will also acquire Auxilla Pharmaceuticals and Research LLP, which was incorporated on May 14, 2020. Forty per cent stake will be acquired by investing Rs 60 crore. Auxilla Pharma is mainly into reformulation/repurposing/novel drug delivery system of existing dosage forms and active pharmaceutical ingredients (APIs).